[ET Net News Agency, 3 September 2025] CLOVER BIO-B (02197) rose 20.7% to HK$1.46.
It hits an intra-day high of HK$1.45, hitting a 52-week high, and an intra-day low of HK$1.18. The total shares traded was 24.14 million, with a value of HK$32.57m. The active buy/sell ratio is 64:36, with net buying turnover of HK$9.39m. MORGAN STANLEY HK SEC accounts for greatest net responsive buying turnover of HK$679,336, with volume weighted average price of HK$1.316. CHINA INV INFO accounts for greatest net responsive selling turnover of HK$1.25m, with volume weighted average price of HK$1.361. The stock has risen a combined 102.8% over the past 4 consecutive trading days.
Basic Information| Nominal | 1.460 | % Chg | +20.66% |
| High | 1.450 | Low | 1.180 |
| Shares Tr | 24.14m | Turnover | 32.57m |
| 10-D SMA | 0.968 | %H.V | 168.141 |
| 20-D SMA | 0.818 | VWAP | 1.349 |
| 50-D SMA | 0.581 | RSI14 | 81.448 |
Status: Hitting a 52-week high, active buy/sell ratio is 64:36, with net buying turnover of HK$9.39m, rising a combined 102.8% over the past 4 consecutive trading days
Performance of stocks in the same sector or of relevance| Stock (Code) | Price (HK$) | Change (%) |
|---|
| CLOVER BIO-B (02197) | 1.46 | +20.66 |
| INNOVENT BIO (01801) | 106.60 | +1.23 |
| KEYMED BIO-B (02162) | 72.20 | +0.28 |
| XTALPI (02228) | 9.96 | +1.22 |
| WUXI XDC (02268) | 65.50 | +6.85 |
| WUXI BIO (02269) | 36.38 | +1.79 |
| WUXI APPTEC (02359) | 117.20 | +0.17 |
| BEIGENE (06160) | 203.80 | +0.49 |
| AKESO (09926) | 155.10 | -0.45 |
| REMEGEN (09995) | 97.50 | +0.78 |
(ed)
Nominal 